Complication Rates Often Higher in Youth With T2DM Versus T1DM

Share this content:
Complication Rates Often Higher in Youth With T2DM Versus T1DM
Complication Rates Often Higher in Youth With T2DM Versus T1DM

WEDNESDAY, March 1, 2017 (HealthDay News) -- Young people with type 2 diabetes are much more likely to show signs of complications from the disease than those who have type 1 diabetes, according to a study published in the Feb. 28 issue of the Journal of the American Medical Association.

The study included 1,746 young people with type 1 diabetes and 272 with type 2 diabetes. They were treated in five different locations in the United States between 2002 and 2015. The average age of the those with type 1 diabetes was 18, and three-quarters were white. For those with type 2 diabetes, the average age was 22, and only about one-quarter were white. Both groups had diabetes for about eight years. Their blood glucose levels were similar.

The researchers found that 19.9 percent of the type 2 group had early signs of possible kidney disease, as did 5.8 percent of those with type 1 diabetes. The investigators also found that 9.1 percent of those with type 2 diabetes had early signs of retinopathy, as did 5.6 percent of the type 1 group. Arterial stiffness was seen in 47.4 percent of those with type 2 diabetes and 11.6 percent with type 1 diabetes. In addition, 21.6 percent of those with type 2 diabetes and 10.1 percent of those with type 1 diabetes had hypertension.

"The one big difference in the kids with type 1 and type 2 was obesity. When we controlled the data for obesity, there was no longer an excess of complications for type 2 diabetes," lead author Dana Dabelea, M.D., Ph.D., a professor of epidemiology and pediatrics at the Colorado School of Public Health in Aurora, told HealthDay. The one bright spot in the findings was that the complications were mostly in the "early or subclinical" stages, Dabelea added.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »